1. Home
  2. SATL vs PBYI Comparison

SATL vs PBYI Comparison

Compare SATL & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Satellogic Inc.

SATL

Satellogic Inc.

N/A

Current Price

$3.35

Market Cap

599.6M

Sector

Technology

ML Signal

N/A

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

N/A

Current Price

$7.75

Market Cap

560.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SATL
PBYI
Founded
2010
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
599.6M
560.1M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
SATL
PBYI
Price
$3.35
$7.75
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $9.50
N/A
AVG Volume (30 Days)
★ 4.4M
433.5K
Earning Date
11-10-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 85.94
N/A
EPS
N/A
★ 0.20
Revenue
$17,707,000.00
★ $27,685,000.00
Revenue This Year
$165.96
N/A
Revenue Next Year
$33.97
$1.33
P/E Ratio
★ N/A
$40.50
Revenue Growth
★ 37.58
N/A
52 Week Low
$1.26
$4.80
52 Week High
$12.00
$11.50

Technical Indicators

Market Signals
Indicator
SATL
PBYI
Relative Strength Index (RSI) 40.53 28.21
Support Level $2.75 $7.57
Resistance Level $3.44 $8.53
Average True Range (ATR) 0.39 0.47
MACD 0.06 -0.32
Stochastic Oscillator 32.30 5.64

Price Performance

Historical Comparison
SATL
PBYI

About SATL Satellogic Inc.

Satellogic Inc is a vertically integrated Earth observation company that designs, manufactures, and operates satellite systems, delivering decision-grade insights at scale to government and commercial customers. Through an end-to-end production and operations model, it provides governments with flexible options across their journey toward sovereign Earth observation. From access to high-frequency imagery and managed space systems to full satellite ownership, to supporting autonomous data availability and long-term technological independence. It has monitoring and alert-driven workflows that help defense and intelligence agencies, civil governments, and commercial operators transition from reactive tasking to proactive decision-making, providing mission-critical data when needed.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: